Clinical Trial Update: Efficacy and Safety of Rapamycin (Sirolimus) in the Treatment of Symptomatic Uterine Fibroids and Leiomyomatosis [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the efficacy and safety of rapamycin (sirolimus) for symptomatic uterine fibroids and leiomyomatosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyomatosis
• Uterine Fibroids

Drugs mentioned

• Rapamycin (Sirolimus) (sirolimus)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Uterine Fibroids | Phase 4 | Status: UNKNOWN